Use of mycophenolate mofetil in steroid-dependent and -resistant nephrotic syndrome
暂无分享,去创建一个
J. Flynn | T. Bunchman | Gina-Marie Barletta | D. Kershaw | Gina-Marie Barletta | William E. Smoyer | Timothy E. Bunchman | Joseph T. Flynn | David B. Kershaw | W. Smoyer
[1] P. Scheel,et al. Successful mycophenolate mofetil treatment of glomerular disease. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[2] S. Mendoza,et al. Management of the difficult nephrotic patient. , 1995, Pediatric clinics of North America.
[3] A. Sedman,et al. Long-term cyclosporine therapy for pediatric nephrotic syndrome: a clinical and histologic analysis. , 1996, Journal of the American Society of Nephrology : JASN.
[4] E. Ingulli,et al. Aggressive, long-term cyclosporine therapy for steroid-resistant focal segmental glomerulosclerosis. , 1995, Journal of the American Society of Nephrology : JASN.
[5] G. Appel,et al. Use of mycophenolate mofetil in resistant membranous nephropathy. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[6] G. Remuzzi,et al. A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group. , 1996, Transplantation.
[7] M. Susin,et al. Remission of relapsing childhood nephrotic syndrome with mycophenolate mofetil , 2000, Pediatric Nephrology.
[8] Y. Vanrenterghem. The use of Mycophenolate Mofetil (Cellcept) in renal transplantation. , 1997, Nephron.